CEFUROXIME SODIUM (se-fyoor-ox'eem) Kefurox, Zinacef CEFUROXIME AXETIL Ceftin Classifications: antiinfective; antibiotic; second-generation cephalosporin Prototype: Cefonicid sodium Pregnancy Category: B |
125 mg, 250 mg, 500 mg tablets; 125 mg/5 mL, 250 mg/5 mL suspension; 750 mg, 1.5 g injection
Semisynthetic second-generation cephalosporin antibiotic with structure similar to that of the penicillins. Resistance against beta-lactamase-producing strains exceeds that of first generation cephalosporins. Antimicrobial spectrum of activity resembles that of cefonicid. Preferentially binds to one or more of the penicillin-binding proteins (PBP) located on cell walls of susceptible organisms. This inhibits third and final stage of bacterial cell wall synthesis, thus killing the bacterium. Partial cross-allergenicity between other beta-lactam antibiotics and cephalosporins has been reported.
Effectively treats bone and joint infections, bronchitis, meningitis, gonorrhea, otitis media, pharyngitis/tonsillitis, sinusitis, lower respiratory tract infections, skin and soft tissue infections, urinary tract infections, and is used for surgical prophylaxis, reducing or eliminating infection.
Infections caused by susceptible organisms in the lower respiratory tract, urinary tract, skin, and skin structures; also used for treatment of meningitis, gonorrhea, and otitis media and for perioperative prophylaxis (e.g., open-heart surgery), early Lyme disease.
Hypersensitivity to cephalosporins and related antibiotics; pregnancy (category B), lactation.
History of allergy, particularly to drugs; penicillin sensitivity; renal insufficiency; history of colitis or other GI disease; potent diuretics.
Moderate to Severe Infections Adult: PO 250500 mg q12h IV/IM 750 mg1.5 g q68h Child (3 mo12 y) : PO 1015 mg/kg (125250 mg) q12h IV/IM 75100 mg/kg/d divided q8h (max: 6 g/d) Neonate: IM/IV 20100 mg/kg/d divided q12h Bacterial Meningitis Adult: IV/IM 3 g q8h Child: IV/IM 200240 mg/kg/d divided q68h; reduced to 100 mg/kg/d upon improvement Surgical Prophylaxis Adult: IV/IM 1.5 g 3060 min before surgery, then 750 mg q8h for 24 h Child: IV/IM Same as for adult |
Intravenous
PREPARE: Direct: Dilute each 750 mg with 9 mL sterile water, D5W, or NS. Intermittent: Further dilute in 50100 mL of compatible solution. Continuous: May be added to 1000 mL of IV compatible solution. ADMINISTER: Direct: Give slowly over 35 min. Intermittent: Give over 30 min. Continuous: Give over 624 h. INCOMPATIBILITIES Solution/additive: aminoglycosides, doxapram, ranitidine, sodium bicarbonate. Y-site: Amiodarone, aminoglycosides, azithromycin, filgrastim, fluconazole, midazolam, sodium bicarbonate, vancomycin, vinorelbine.
|
Cefuroxime causes false-positive (black-brown or green-brown color) urine glucose reaction with copper reduction reagents, e.g., Benedict's or Clinitest, but not with enzymatic glucose oxidase reagents, e.g., Clinistix, TesTape. False-positive direct Coombs' test (may interfere with cross-matching procedures and hematologic studies) has been reported.
Assessment & Drug Effects
Patient & Family Education